Head-to-Head

BillionToOne, Inc. Class A Common Stock vs. Caris Life Sciences, Inc. Common Stock

BLLN

BillionToOne, Inc. Class A Common Stock

$105.92 -4.29%

VS CAI

Caris Life Sciences, Inc. Common Stock

$29.98 -3.04%

Caris Life Sciences, Inc. Common Stock (CAI) comes out ahead, leading on 7 of 9 compared factors.

Size & Scale

BLLNCAI
Market Cap $5.00 billion $8.74 billion
Revenue (TTM) $397.41 million $989.61 million
Net Income (TTM) $37.71 million $105.14 million

CAI leads on 3 of 3 size & scale factors.

Valuation

BLLNCAI
P/E Ratio 102.83 17.74
Price / Book 9.31 14.77
Price / Sales 12.58 8.83

CAI leads on 2 of 3 valuation factors.

Profitability

BLLNCAI
Net Margin 9.49% 10.62%
Return on Equity 7.03% 17.77%

CAI leads on 2 of 2 profitability factors.

Dividend

BLLNCAI
Dividend Yield — 4.00%
Payout Ratio — 71.01

BLLN and CAI split the dividend factors evenly.

Risk & Sentiment

BLLNCAI
Short Interest 0.12% 0.13%

BLLN leads on 1 of 1 risk & sentiment factors.

Dig deeper: BLLN overview, BLLN financials, CAI overview, CAI financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.